🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05864638
Recruiting Observational

Acute Ischemic Stroke EndoVascular Therapy: a Multicenter REGISTRY Study

NCT05864638 · tracked via the Priya Life Science China tracker
Sponsor
Changhai Hospital
Phase
Observational
Started
2023-05-10
Last updated
2025-01-27

Condition(s) studied

Acute Ischemic StrokeLarge Vessel OcclusionThrombectomyThrombosis

Investigational drug(s) / intervention(s)

Endovascular treatment

Endovascular treatment: Endovascular treatment, such as mechanical thrombectomy with stent, aspiration catheter or stent assisted by intermediate aspiration catheter, as well as combination of mechanical thrombectomy with intra-arterial thrombolysis

Study summary

A Multicenter Registry of Endovascular Treatment for Acute Ischemic Stroke.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Acute ischemic stroke caused by anterior or posterior circulation vessel occlusion confirmed by computed tomography angiography (CTA) or magnetic resonance angiography (MRA) or digital subtraction angiography (DSA) 2. Undergo intravascular therapy (i.e. access to a cath lab and an arterial puncture) 3. The patient or his/her legal representative agreed to participate in the study and has signed the informed consent. Exclusion Criteria: 1\) No exclusion criteria

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Jianimin Liu Shanghai China Recruiting

More Changhai Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05864638 on ClinicalTrials.gov ↗ ← All trials in China